(Q48013267)

7 February 2018

title

Possible role of nitric oxide in malarial immunosuppression. (English)

1 reference

7 February 2018

0 references

1 reference

Rockett KA

1

1 reference

7 February 2018

Awburn MM

2

1 reference

7 February 2018

Rockett EJ

3

1 reference

7 February 2018

Cowden WB

4

1 reference

7 February 2018

Clark IA

5

1 reference

7 February 2018

publication date

1 May 1994

1 reference

7 February 2018

published in

Parasite Immunology

1 reference

7 February 2018

volume

16

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

243-249

1 reference

7 February 2018

Immunosuppression induced by nitric oxide and its inhibition by interleukin-4

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Roles of tumour necrosis factor in the illness and pathology of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Immunosuppression in children with malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Changes in the capacity of macrophages and T cells to produce interleukins during marine malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Inactivation of ribonucleotide reductase by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

The role of TH1 and TH2 cells in a rodent malaria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Malarial immunodepression in vitro: adherent spleen cells are functionally defective as accessory cells in the response to horse erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Impairment of the immune response to vaccination after acute malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.1994.TB00346.X

10.1111/J.1365-3024.1994.TB00346.X

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

8072768

1 reference

7 February 2018